GREENWICH LIFESCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events

On July 12, 2022, Greenwich LifeSciences, Inc. issued a press release announcing that the Food and Drug Administration has removed the previously disclosed clinical hold on the Flamingo-01 Phase III clinical trial and is allowing the clinical trial to proceed. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



  99.1   Press release dated July 12, 2022.
  104  Cover Page Interactive Data File (embedded within the Inline XBRL document)

-2-

© Edgar Online, source Glimpses